Navigation Links
Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil™
Date:7/7/2011

SAO PAULO and NEW BRUNSWICK, N.J., July 7, 2011 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that the company has entered into an agreement to become a global sponsor of the 2014 FIFA World Cup Brazil™, becoming the eighth and final FIFA World Cup™ Sponsor.

With this sponsorship, Johnson & Johnson will be the exclusive and Official Healthcare Sponsor, with the ability to activate across their Consumer, Medical Devices & Diagnostics and Pharmaceutical businesses.  Johnson & Johnson will receive exclusive global marketing rights related to the FIFA Confederations Cup Brazil 2013 and 2014 FIFA World Cup™.

"The FIFA World Cup™ unites people of all cultures, ages and socioeconomic levels like no other event, and we're excited to tap into this passion and reach to further impact health and wellness around the world," said Brian Perkins, Corporate Vice President, Corporate Affairs, Johnson & Johnson. "Through this sponsorship, the company will be able to reach new professionals and consumers and deepen our commitment and connection to the people and communities we serve."

Through its engagement with the FIFA World Cup™, Johnson & Johnson will provide access to its broad range of products and services – including vision, oral, sun, skin and wound care products – and encourage healthier lifestyles for football fans around the world.

"Having a global, broadly based and trusted company like Johnson & Johnson as a FIFA World Cup™ Sponsor is a great asset for FIFA and we are honoured to welcome them on board," said Thierry Weil, FIFA Marketing Director. "We look forward to working closely with Johnson & Johnson on our shared mission of making the 2014 World Cup an exciting and memorable event."

"Johnson & Johnson has a longstanding history of serving the people and communities of Brazil and we are thrilled by the opportunity to support the World Cup in Brazil and share in the pride of this spectacular event," said Maria Eduarda Kertesz, Brazil's Managing Director for Johnson & Johnson – Consumer Brands. "Given the inherent passion Brazilians have for the sport, we hope to leverage this sponsorship to support the communities in which we live and work and improve Brazilian quality of life."  

Johnson & Johnson has a nearly 80 year history in Brazil of addressing the health care needs of the Brazilian people through innovative health care products and services and an unwavering commitment to community engagement initiatives. Brazil represents an important emerging market for Johnson & Johnson providing a broad range of consumer, medical devices and diagnostics and pharmaceutical products.

About Johnson & Johnson

Caring for the world, one person at a time...inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 115,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , Feb. 27, 2017  A ... P. Vallely , MBBS, PhD, FRACS, of  Sydney ... University of Sydney will be published in ... of the American College of Cardiology ... beating heart bypass surgery technique (anOPCABG) reduced ...
(Date:2/27/2017)... Biophysics Corporation, a global medical device manufacturer based in ... growth in 2016 when compared to the previous year based ... fueled by its AffloVest® sales in the United ... global sales of surgical product lines. Said H. ... 25 th year in delivering high-quality, innovative medical devices ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... ... overview on laser diffraction analysis as a tool to characterize particle size distributions ... potential to obtain improved results and novel scientific findings. It describes methods of ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... BC (PRWEB) , ... February 27, 2017 , ... ... drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ ... to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... San Francisco and environs, is proud to announce an upgrade to the company's ... the upgraded Yelp page on topics as diverse as Platelet Rich Plasma (PRP) ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
Breaking Medicine News(10 mins):